MRNS - The Gross Law Firm Notifies Shareholders of Marinus Pharmaceuticals Inc.(MRNS) of a Class Action Lawsuit and an Upcoming Deadline | Benzinga
NEW YORK, July 01, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS).
Shareholders who purchased shares of MRNS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.
CONTACT US HERE:
CLASS PERIOD: March 17, 2021 to May 7, 2024
ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) defendants understated the risk of failure to meet the early-stopping criteria in the Randomized Therapy in Status Epilepticus Trial (RAISE); (2) ...
MRNS) of a Class Action Lawsuit and an Upcoming Deadline>Full story available on Benzinga.com